Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma. (Q34552660)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15547181 AND SRC:MED&resulttype=core&format=json

5 January 2020

title

Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15547181 AND SRC:MED&resulttype=core&format=json

5 January 2020

main subject

phase III clinical trial

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15547181 AND SRC:MED&resulttype=core&format=json

5 January 2020

Hani Gabra

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15547181 AND SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Paul A Vasey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15547181 AND SRC:MED&resulttype=core&format=json

5 January 2020

Alan Gordon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15547181 AND SRC:MED&resulttype=core&format=json

5 January 2020

Rob Coleman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15547181 AND SRC:MED&resulttype=core&format=json

5 January 2020

Ronnie Atkinson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15547181 AND SRC:MED&resulttype=core&format=json

5 January 2020

David Parkin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15547181 AND SRC:MED&resulttype=core&format=json

5 January 2020

James Paul

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15547181 AND SRC:MED&resulttype=core&format=json

5 January 2020

Andrea Hay

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15547181 AND SRC:MED&resulttype=core&format=json

5 January 2020

Stan B Kaye

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15547181 AND SRC:MED&resulttype=core&format=json

5 January 2020

Scottish Gynaecological Cancer Trials Group

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15547181 AND SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

English

0 references

publication date

1 November 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15547181 AND SRC:MED&resulttype=core&format=json

Journal of the National Cancer Institute

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15547181 AND SRC:MED&resulttype=core&format=json

5 January 2020

volume

96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15547181 AND SRC:MED&resulttype=core&format=json

5 January 2020

issue

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15547181 AND SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

1682-1691

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15547181 AND SRC:MED&resulttype=core&format=json

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

5 January 2020

cites work

1 reference

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results

21 January 2018

1 reference

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

21 January 2018

1 reference

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.

21 January 2018

1 reference

Relationships between the structure of taxol analogs and their antimitotic activity

21 January 2018

1 reference

Phase II trials of docetaxel (Taxotere) in advanced ovarian cancer--an updated overview

21 January 2018

1 reference

A phase II study of docetaxel in paclitaxel-resistant ovarian and peritoneal carcinoma: a Gynecologic Oncology Group study

21 January 2018

1 reference

Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer

21 January 2018

1 reference

Clinical trials of nimodipine as a potential neuroprotector in ovarian cancer patients treated with cisplatin

21 January 2018

1 reference

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

21 January 2018

1 reference

A sharper Bonferroni procedure for multiple tests of significance

21 January 2018

1 reference

Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial

21 January 2018

1 reference

Neurotoxicity of taxanes: symptoms and quality of life assessment

21 January 2018

1 reference

Neuromuscular toxicities of paclitaxel 210 mg m(-2) by 3-hour infusion

21 January 2018

1 reference

Peripheral neurotoxicity induced by docetaxel.

21 January 2018

1 reference